Care360® EHR

In this 1-minute video, Boston-area neurologist Paulo Andre, MD shares how Care360 EHR helps him easily obtain and share medical information across three hospitals, from any location.


Read more

ImmunoCAP® specific IgE blood test

ImmunoCAP provides a clinically relevant means of identifying specific allergen sensitivities in patients with a confirmed allergy. Learn more.


Read more

Meet 14-3-3ŋ (eta), a biomarker for RA

Dr. Walter Maksymowych of the University of Alberta discusses the pathophysiology of 14-3-3ŋ (eta), an inflammatory mediator with diagnostic and prognostic value for rheumatoid arthritis, as well as a new assay that measures 14-3-3ŋ.


Read more

Prescription Drug Monitoring: available tests

Check our comprehensive menu of clinical drug monitoring tests to learn whether the therapies you prescribe are included.


Read more

Which arthritis biomarkers?

Watch as a rheumatology expert compares rheumatoid arthritis (RA) and osteoarthritis (OA), the difficulty of differential diagnosis, and how the limitations of current antibody biomarkers can be overcome by the 14-3-3ŋ (eta) biomarker.


Read more

Prescription Drug Monitoring: tests & services

Discover the range of clinical drug monitoring services available from Quest, including medMATCH® reports and Quanum™ solutions.


Read more

Know a more comprehensive story: the role of injury and inflammation in cardiovascular disease risk

See how lipoprotein risk factors and inflammatory markers can offer you deeper insight into a patient's risk for cardiovascular disease progression in this useful infographic.


Read more

Inflammatory markers in cardiovascular health: a quick overview

In addition to lipids, measuring inflammatory biomarkers in patients being treated for elevated LDL-C can help physicians see the complete picture, uncovering a patient’s hidden risk for cardiac events and enabling them to take the right actions.


Read more

Size and density matter: how advanced lipid testing can uncover residual risk

Cardiovascular risk assessment has evolved beyond standard lipid panel values. Assessing emerging biomarkers can help physicians improve their management of cardiovascular patients, for better health and practice outcomes.


Read more

Why physicians need to integrate Clinical Drug Monitoring into their practice

In this video, pain specialist Jeff Gudin, MD of Englewood Hospital & Medical Center explains why and who to monitor to promote safety and compliance in patients on chronic opioid therapy.


Read more
email icon

Subscribe to Primary Insights

Get the clinical insights most relevant to you and your patients, from the lab committed to knowing.